Osteopontin and its integrin receptor α(v)β3 are upregulated during formation of the glial scar after focal stroke

Stroke

Volumn 29, Issue 8, 1998, Pages 1698-1707

  Ellison, Julie A ^b   Velier, James J ^b   Spera, Patricia ^b   Jonak, Zdenka L ^a   Wang, Xinkang ^b   Barone, Frank C ^b   Feuerstein, Giora Z ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b NONE

Author keywords

Astrocyte; Cerebral ischemia; Infarcts; Macrophages; Microglia; Neuroglia

Indexed keywords

INTEGRIN; MESSENGER RNA; OSTEOPONTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN INFARCTION; CONTROLLED STUDY; GLIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGE; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SCAR; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE; WOUND HEALING;

EID: 0031904534     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.8.1698     Document Type: Article

References (45)

1. Reier PJ, Stensaas LJ, Guth L. The astrocytic scar as an impediment to regeneration in the central nervous system. In: Kao RPBCC, Reier PJ, eds. Spinal Cord Reconstruction. New York, NY: Raven Press; 1983: 163-195.
2. Clark RK, Lee EV, Fish CJ, White RF, Price WJ, Jonak ZL, Feuerstein GZ, Barone FC. Development of tissue damage, inflammation and resolution following stroke: an immunohistochemical and quantitative planimetric study. Brain Res Bull. 1993;31:565-572.
3. Fitch MT, Silver J. Activated macrophages and the blood-brain barrier: inflammation after CNS injury leads to increases in putative inhibitory molecules. Exp Neurol. 1997;148:587-603.
4. Ide CF, Scripter JL, Coltman BW, Dotson RS, Snyder DC, Jelaso A. Cellular and molecular correlates to plasticity during recovery from injury in the developing mammalian brain. Prog Brain Res. 1996;108:365-377.
5. Reier PJ. Gliosis following CNS injury: the anatomy of astrocytic scars and their influences on axonal elongation. In: Fedoroff S, Vernadiakis A, eds. Cell Biology and Pathology of Astrocytes. New York, NY: Academic Press; 1986:263-324.
6. Garcia H, Yoshida Y, Chen H, Li Y, Zhang ZG, Lian J, Chen S, Chopp M. Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat. Am J Pathol. 1993;142:623-635.
7. Gehrmann J, Bonnekoh P, Miyazawa T, Hossmann K-A, Kreutzber GW. Immunocytochemical study of an early microglial activation in ischemia. J Cereb Blood Flow Metab. 1992;12:257-269.
8. Lehrmann E, Christensen T, Zimmer J, Diemer NH, Finsen B. Microglial and macrophage reactions mark progressive changes and define the penumbra in the rat neocortex and striatum after transient middle cerebral artery occlusion. J Comp Neurol. 1997;386:461-476.
9. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992;69:11-25.
10. Laywell ED, Dorries U, Bartsch U, Faissner A, Schachner M, Steindler DA. Enhanced expression of the developmentally regulated extracellular matrix molecule tenascin following adult brain injury. Proc Natl Acad Sci U S A. 1992;89:2634-2638.
11. Okada Y, Copeland BR, Hamann GF, Koziol JA, Cheresh DA, del Zoppo GJ. Integrin alphavbeta3 is expressed in selected microvessels after focal cerebral ischemia. Am J Pathol. 1996;149:37-44.
12. Wagner S, Tagaya M, Koziol JA, Quaranta V, del Zoppo GJ. Rapid disruption of an astrocyte interaction with the extracellular matrix mediated by integrin alpha 6 beta 4 during focal cerebral ischemia/ reperfusion. Stroke. 1997;28:858-865.
13. Cheresh DA, Spiro RC. Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to fibronectin, fibrinogen and von Willebrand factor. J Biol Chem. 1987:262:17703-17711.
14. Lawler J, Weinstein R, Hynes RO. Cell attachment to thrombospondin: the role of RGD and integrin receptors. J Cell Biol. 1988;107:2351-2361.
15. 3 in promoting cellular attachment and spreading on fibronectin. J Cell Biol. 1990;111:2795-2800.
16. Kramer RH, Cheng Y-F, Clyman R. Human microvascular endothelial cells use β1 and β3 integrin receptor complexes to attach to laminin. J Cell Biol. 1990;111:1233-1243.
17. Reinholt FP, Hultenby K, Oldberg A, Heinegard D. Osteopontin: a possible anchor of osteoclasts to bone. Proc Natl Acad Sci U S A. 1990; 87:4473-4475.
18. Wang XK, Louden C, Yue T-L, Ellison JA, Barone FC, Solleveld HA, Feuerstein GZ. Regulation of osteopontin expression in brain ischemia: implication for matrix remodeling and astrocyte function. J Neurosci. 1998;18:2075-2083.
19. Liaw L, Almeida M, Hart CH, Schwartz SM, Giachelli CM. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res. 1994;74:214-224.
20. Murry CE, Giachelli CM, Schwartz SM, Vracko R. Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol. 1994;145: 1450-1462.
21. Panda D, Kundu GC, Lee BI, Peri A, Fohl D, Chackalaparampil I, Mukherjee BB, Li XD, Mukherjee DC, Seides S, Rosenberg J, Stark K, Mukherjee AB. Potential roles of osteopontin and alphavbeta3 integrin in the development of coronary artery restenosis after angioplasty. Proc Natl Acad Sci U S A. 1997;94:9308-9313.
22. Yue T-L, Mckenna PJ, Ohlstein EH, Farach-Carson MC, Bulter WT, Johanson K, McDevitt P, Feuerstein GZ, Stadel JM. Osteopontin-stimulated vascular smooth muscle cell migration is mediated by β3 integrin. Exp Cell Res. 1994;214:459-464.
23. Weintraub AS, Giachelli CM, Krauss RS, Almeida M, Taubman MB. Autocrine secretion of osteopontin by vascular smooth muscle cells regulates their adhesion to collagen gels. Am J Pathol. 1996;149:259-272.
24. Liaw L, Skinner MP, Raines EW, Ross R, Cheresh DA, Schwartz SM, Giachelli CM. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins: role of smooth muscle cell migration to osteopontin in vitro. J Clin Invest. 1995;95:713-724.
25. Giachelli CM, Liaw L, Murry CE, Schwartz SM, Almeida M. Osteopontin expression in cardiovascular diseases. Ann N Y Acad Sci. 1995;760:109-126.
26. Barone FC, Hillegass LM, Tzimas MN, Schmidt DB, Foley JJ, White RF, Price WJ, Feuerstein GZ, Clark RK, Griswold DE, Sarau HM. Time-related changes in myeloperoxidase activity and leukotriene by receptor binding reflect leukocyte influx in cerebral focal stroke. Mol Chem Neuropathol. 1995;24:13-30.
27. Ellison JA, Scully SA, de Vellis J. Evidence for neuronal regulation of oligodendrocyte development: cellular localization of platelet-derived growth factor α receptor and A-chain mRNA during cerebral cortex development in the rat. J Neurosci Res. 1996;45:28-39.
28. Wang XK, Louden C, Ohlstein EH, Stadel JM, Gu J-L, Yue T-L. Osteopontin expression in platelet-derived growth factor stimulated vascular smooth muscle cells and carotid artery after balloon angioplasty. Arterioscler Thromb Vasc Biol. 1996;16:1365-1372.
29. Kennett RH, Jonak ZL, Bechtol KB. Monoclonal antibodies to human tumor associated antigens. In: Kennett RH, McKearn T, Bechtol K, eds. Monoclonal Antibodies. New York, NY: Plenum Press; 1980:155-168.
30. Kimbro KS, Saavedra RA. The puerap motif in the promoter of the mouse osteopontin gene. Ann N Y Acad Sci. 1995;760:319-320.
31. Sauk JJ, Van Kampen CL, Norris K, Foster R, Somerman MJ. Expression of constitutive and inducible HSP70 and HSP47 is enhanced in cells persistently spread on opn or collagen. Biochem Biophys Res Commun. 1990;2:135-142.
32. Denhardt DT, Chambers AF. Overcoming obstacles to metastasis: defenses against host defenses: osteopontin (opn) as a shield against attack by cytotoxic host cells. J Cell Biochem. 1994;56:48-51.
33. Hwang S-M, Lopez CA, Heck DE, Gardner CR, Laskin DL, Laskin JD, Denhardt DT. Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells. J Biol Chem. 1994;269:711-715.
34. Massa SM, Swanson RA, Sharp FR. The stress gene response in brain. Cerebrovasc Brain Metab Rev. 1996;8:95-158.
35. Coyle P. Spatial relations of dorsal anastomoses and lesion border after middle cerebral artery occlusion. Stroke. 1987;18:1133-1140.
36. Li Y, Chopp M, Zhang ZG, Zhang RL. Expression of glial fibrillary acidic protein in areas of focal cerebral ischemia accompanies neuronal expression of 72-kDa heat shock protein. J Neural Sci. 1995;128:134-142.
37. Petito CK, Morgello S, Felix JC, Lesser ML. The two patterns of reactive astrocytosis in postischemic rat brain. J Cereb Blood Flow Metab. 1990; 10:850-859.
38. Tawil NJ, Wilson P, Carbonetto S. Expression and distribution of functional integrins in rat CNS glia. J Neurosci Res. 1994;39:436-447.
39. v Integrin subunit is predominantly located in nervous tissue and skeletal muscle during mouse development. Dev Dyn. 1994;201:108-120.
40. Brooks PC, Clark RAF, Cheresh DA. Requirement for vascular for angiogenesis. Science. 1994;264:569-571.
41. Hruska KA, Rolnick F, Huskey M, Alvarez U, Cheresh D. Engagement of the osteoclast intcgrin alpha v beta 3 by osteopontin stimulates phosphatidylinositol 3-hydroxyl kinase activity. Endocrinology. 1995;136:2984-2992.
42. Bianchi R, Garbuglia M, Verzini M, Giambanco I, Spreca A, Donato R. S-100 protein and annexin II2-p11(2) (calpactin I) act in concert to regulate the state of assembly of GFAP intermediate filaments. Biochem Biophys Res Commun. 1995;208:910-918.
43. Yamamoto-Hino M, Miyawaki A, Kawano H, Sugiyama T, Furuichi T, Hasegawa M, Mikoshiba K. Immunohistochemical study of inositol 1,4,5-trisphosphate receptor type 3 in rat central nervous system. Neuroreport. 1995;6:273-276.
44. Tremble P, Chiquet-Ehrismann R, Werb Z. The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. Mol Biol Cell. 1994;5:439-453.
45. Stromblad S, Becker JC, Yebra M, Brooks PC, Cheresh DA. Suppression of p53 activity and p21WAF1/IP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis. J Clin Invest. 1996;98: 426-433.